The Telegraph previously reported that Biomet would begin informal talks about a potential merger with Smith & Nephew. Sky News also reported earlier in the week that Smith & Nephew had rejected an $11 billion takeover from Johnson & Johnson in December. Stock prices jumped and then retreated after this announcement was made.
Smith & Nephew has an enterprise value of $10.3 billion. The company issued a statement today clarifying that it is not engaging in any discussions which could lead to a merger or takeover.
Read the Smith & Nephew release on the denial of mergers or acquisitions.
Read the report from The New York Times about Smith & Nephew.
Read other coverage on Smith & Nephew:
– Smith & Nephew Shares Jump After Rejecting Johnson & Johnson Acquisition
– Smith & Nephew Responds to FDA Letter of Warning
– Smith & Nephew Adds 100 Employees
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
